Biochip-based approach for comprehensive pharmacogenetic testing.

Ikonnikova, Anna Yu; Filippova, Marina A; Surzhikov, Sergey A; Pozhitnova, Victoria O; Kazakov, Ruslan E; Lisitsa, Tatiana S; Belkov, Sergey A; Nasedkina, Tatiana V

Ikonnikova, Anna Yu; Filippova, Marina A; Surzhikov, Sergey A; Pozhitnova, Victoria O; Kazakov, Ruslan E; Lisitsa, Tatiana S; Belkov, Sergey A; Nasedkina, Tatiana V.

Afiliação

Ikonnikova AY; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Filippova MA; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Surzhikov SA; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Pozhitnova VO; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Kazakov RE; Federal State Budgetary Institution "Scientific Centre for Expert Evaluation of Medicinal Products" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Lisitsa TS; Moscow Clinical Scientific Center named after Loginov Moscow Healthcare Department, Moscow, Russia.
Belkov SA; Federal State Budgetary Institution "Scientific Centre for Expert Evaluation of Medicinal Products" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Nasedkina TV; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.

Drug Metab Pers Ther ; 2020 Dec 14.

Article em En | MEDLINE | ID: mdl-33780199

Palavras-chave

biochip; cardiovascular diseases; personalized therapy; pharmacogenetic testing

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Drug Metab Pers Ther Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Federação Russa País de publicação: Alemanha

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google